Cohance Lifesciences Ltd.

₹1004.5

Cohance Lifesciences Ltd.

₹1004.5

₹1004.5

-4.8 (-0.48%) - 14 Jun 2025 04:20 PM

About Company

Suven Pharmaceuticals Limited is a bio-pharmaceutical company, incorporated with the object of being engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies. Suven Pharma Inc., a Delaware Company, is a WOS (wholly owned subsidiary) of SPL, is a SPV (Special Purpose Vehicle) created on 9th March 2019, for undertaking various business opportunities in Pharma Industry.

Market Cap. ₹ 38,429 Cr.
52 Week - High/Low ₹ 1,360/656
P/E Ratio 93.97
P/B Ratio 18.69
Enterprise Value ₹ 38,468 Cr.
ROE % 16.03
RSI Value -
EMA 50 -
EMA 200 -
Market Cap. ₹ 38,429 Cr.
52 Week - High/Low ₹ 1,360/656
P/E Ratio 95.39
P/B Ratio 18.74
Enterprise Value ₹ 39,169 Cr.
ROE % 15.87
RSI Value -
EMA 50 -
EMA 200 -

Growth

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.